Chao Liu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Dna Methylation

Newly Diagnosed

Top Venues

CNS neuroscience & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Chao Liu, Shuwen Kuang, Tianxiang Huang, Jun Wu, Longbo Zhang, Xuan Gong
Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study. CNS neuroscience & therapeutics 30 (4) (2024)
Chao Liu, Shuwen Kuang, Tianxiang Huang, Jun Wu, Longbo Zhang, Xuan Gong
Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study. CNS neuroscience & therapeutics 30 (4) (2024)
Chao Liu, Shuwen Kuang, Tianxiang Huang, Jun Wu, Longbo Zhang, Xuan Gong
Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study. CNS neuroscience & therapeutics 30 (4) (2024)
Chao Liu, Shuwen Kuang, Tianxiang Huang, Jun Wu, Longbo Zhang, Xuan Gong
Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study. CNS neuroscience & therapeutics 30 (4) (2024)
Chao Liu, Shuwen Kuang, Tianxiang Huang, Jun Wu, Longbo Zhang, Xuan Gong
Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study. CNS neuroscience & therapeutics 30 (4) (2024)
Chao Liu, Shuwen Kuang, Tianxiang Huang, Jun Wu, Longbo Zhang, Xuan Gong
Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study. CNS neuroscience & therapeutics 30 (4) (2024)
Chao Liu, Shuwen Kuang, Lei Wu, Quan Chen, Xuan Gong, Jun Wu, Longbo Zhang
Radiotherapy and radio-sensitization in H3 K27M -mutated diffuse midline gliomas. CNS neuroscience & therapeutics (2023)
Xuan Gong, Shuwen Kuang, Dongfeng Deng, Jun Wu, Longbo Zhang, Chao Liu
Differences in survival prognosticators between children and adults with H3K27M-mutant diffuse midline glioma. CNS neuroscience & therapeutics (2023)
Lei She, Xuan Gong, Lin Su, Chao Liu
Radiotherapy Plus Temozolomide With or Without Nimotuzumab Against the Newly Diagnosed EGFR-Positive Glioblastoma: A Retrospective Cohort Study. The oncologist (2022)
Xuan Gong, Zhou Chen, Jason J Hu, Chao Liu
Advances of Electroporation-Related Therapies and the Synergy with Immunotherapy in Cancer Treatment. Vaccines 10 (11) (2022)